Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
Prospective Randomized Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
Status: Enrolling
Updated:  12/4/2014
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
Prospective Randomized Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
Status: Enrolling
Updated: 12/4/2014
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Lamotrigine Bioequivalence
Evaluation of Bioequivalence of Lamotrigine Tablets in Epileptic Patients
Status: Enrolling
Updated:  3/12/2015
University of Maryland
mi
from
Baltimore, MD
Lamotrigine Bioequivalence
Evaluation of Bioequivalence of Lamotrigine Tablets in Epileptic Patients
Status: Enrolling
Updated: 3/12/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary
A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary
Status: Enrolling
Updated:  5/22/2015
Stanford Hospital and Clinics
mi
from
Stanford, CA
A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary
A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary
Status: Enrolling
Updated: 5/22/2015
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Mobile, AL
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Little Rock, AR
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Fairfield, CT
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Fairfield, CT
Click here to add this to my saved trials
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Bethesda, MD
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Dallas, TX
Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Antiepileptic Drugs and Osteoporotic Prevention Trial
Antiepileptic Drugs and Osteoporotic Prevention Trial
Status: Enrolling
Updated:  7/23/2015
VA Boston Healthcare System
mi
from
Boston, MA
Antiepileptic Drugs and Osteoporotic Prevention Trial
Antiepileptic Drugs and Osteoporotic Prevention Trial
Status: Enrolling
Updated: 7/23/2015
VA Boston Healthcare System
mi
from
Boston, MA
Click here to add this to my saved trials
Medication Adherence in Individuals With Epilepsy
Best Practices and Challenges in Medication Adherence for Individuals With Epilepsy
Status: Enrolling
Updated:  7/29/2015
Columbia University Morningside Campus
mi
from
New York, NY
Medication Adherence in Individuals With Epilepsy
Best Practices and Challenges in Medication Adherence for Individuals With Epilepsy
Status: Enrolling
Updated: 7/29/2015
Columbia University Morningside Campus
mi
from
New York, NY
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Tucson, AZ
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Little Rock, AR
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Los Angeles, CA
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Stanford, CA
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Stanford, CA
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Denver, CO
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Washington,
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Jacksonville, FL
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Miami, FL
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Orlando, FL
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Tallahassee, FL
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Tampa, FL
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Atlanta, GA
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Augusta, GA
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Lexington, KY
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
St. Paul, MN
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
St. Paul, MN
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Kansas City, MO
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Chapel Hill, NC
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Raleigh, NC
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Akron, OH
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Columbus, OH
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Portland, OR
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Nashville, TN
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Dallas, TX
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Fort Worth, TX
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated:  8/19/2015
GSK Investigational Site
mi
from
Perth,
Pediatric Epilepsy Trial in Subjects 1-24 Months
A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
Status: Enrolling
Updated: 8/19/2015
GSK Investigational Site
mi
from
Perth,
Click here to add this to my saved trials
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
Status: Enrolling
Updated:  8/27/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
Status: Enrolling
Updated: 8/27/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
Status: Enrolling
Updated:  8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
Status: Enrolling
Updated: 8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pediatric Seizure Movement Bed Alarm
Pediatric Seizure Alarm: A Pilot Study to Establish Efficacy Parameters
Status: Enrolling
Updated:  9/2/2015
LeBonheur Children's Medical Center
mi
from
Memphis, TN
Pediatric Seizure Movement Bed Alarm
Pediatric Seizure Alarm: A Pilot Study to Establish Efficacy Parameters
Status: Enrolling
Updated: 9/2/2015
LeBonheur Children's Medical Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Illinois
mi
from
Chicago, IL
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, North Carolina
mi
from
Charlotte, NC
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, North Carolina
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Texas
mi
from
Austin, TX
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Texas
mi
from
Houston, TX
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Texas
mi
from
Houston, TX
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Texas
mi
from
San Antonio, TX
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings
Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings
Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Language and Emotional Function in Patients With Temporal Lobe Epilepsy
Functional MRI (fMRI) and Diffusion Tensor Imaging (DTI) in Temporal Lobe Epilepsy
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Language and Emotional Function in Patients With Temporal Lobe Epilepsy
Functional MRI (fMRI) and Diffusion Tensor Imaging (DTI) in Temporal Lobe Epilepsy
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (EQUIGEN Chronic-Dose Study)
Status: Enrolling
Updated:  9/29/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (EQUIGEN Chronic-Dose Study)
Status: Enrolling
Updated: 9/29/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (EQUIGEN Chronic-Dose Study)
Status: Enrolling
Updated:  9/29/2015
Drake University
mi
from
Des Moines, IA
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (EQUIGEN Chronic-Dose Study)
Status: Enrolling
Updated: 9/29/2015
Drake University
mi
from
Des Moines, IA
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (EQUIGEN Chronic-Dose Study)
Status: Enrolling
Updated:  9/29/2015
University of Kansas
mi
from
Kansas City, KA
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (EQUIGEN Chronic-Dose Study)
Status: Enrolling
Updated: 9/29/2015
University of Kansas
mi
from
Kansas City, KA
Click here to add this to my saved trials